1321 related articles for article (PubMed ID: 28356032)
1. Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature.
Manolis AS
Rev Recent Clin Trials; 2017; 12(2):129-138. PubMed ID: 28356032
[TBL] [Abstract][Full Text] [Related]
2. Simplified percutaneous closure of patent foramen ovale and atrial septal defect with use of plain fluoroscopy: Single operator experience in 110 consecutive patients.
Manolis AS; Koulouris S; Rouska E; Pyrros J
Indian Heart J; 2018; 70(1):24-31. PubMed ID: 29455783
[TBL] [Abstract][Full Text] [Related]
3. Transcatheter interatrial septal defect closure in a large cohort: midterm follow-up results.
Aytemir K; Oto A; Özkutlu S; Canpolat U; Kaya EB; Yorgun H; Şahiner L; Sunman H; Ateş AH; Kabakçı G
Congenit Heart Dis; 2013; 8(5):418-27. PubMed ID: 23601507
[TBL] [Abstract][Full Text] [Related]
4. Transcatheter patent foramen ovale closure is effective in reducing migraine independently from specific interatrial septum anatomy and closure devices design.
Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Braggion G; Chinaglia M; Roncon L
Cardiovasc Revasc Med; 2010; 11(1):29-33. PubMed ID: 20129358
[TBL] [Abstract][Full Text] [Related]
5. Improvement of migraine headaches after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism.
Wahl A; Praz F; Tai T; Findling O; Walpoth N; Nedeltchev K; Schwerzmann M; Windecker S; Mattle HP; Meier B
Heart; 2010 Jun; 96(12):967-73. PubMed ID: 20538672
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous closure of inter-atrial communications (atrial septal defect and patent foramen ovale): single-centre experience and mid-term follow-up.
Van de Bruaene A; Stroobants D; Benit E
Acta Cardiol; 2015 Apr; 70(2):133-40. PubMed ID: 26148372
[TBL] [Abstract][Full Text] [Related]
7. Influence of hospital volume on outcomes of percutaneous atrial septal defect and patent foramen ovale closure: a 10-years US perspective.
Singh V; Badheka AO; Patel NJ; Chothani A; Mehta K; Arora S; Patel N; Deshmukh A; Shah N; Savani GT; Rathod A; Manvar S; Thakkar B; Panchal V; Patel J; Palacios IF; Rihal CS; Cohen MG; O'Neill W; De Marchena E
Catheter Cardiovasc Interv; 2015 May; 85(6):1073-81. PubMed ID: 25534392
[TBL] [Abstract][Full Text] [Related]
8. The Flatstent versus the conventional umbrella devices in the percutaneous closure of patent foramen ovale.
Aral M; Mullen M
Catheter Cardiovasc Interv; 2015 May; 85(6):1058-65. PubMed ID: 25413379
[TBL] [Abstract][Full Text] [Related]
9. Atrial septal defect and patent foramen ovale: early and long-term effects on endothelial function after percutaneous occlusion procedure.
Scicchitano P; Gesualdo M; Cortese F; Acquaviva T; de Cillis E; Bortone AS; Ciccone MM
Heart Vessels; 2019 Sep; 34(9):1499-1508. PubMed ID: 30895384
[TBL] [Abstract][Full Text] [Related]
10. Risk of cerebral embolism after interventional closure of symptomatic patent foramen ovale or atrial septal defect: a diffusion-weighted MRI and neuron-specific enolase-based study.
Oktay Tureli H; Ungan I; Tureli D; Demir B; Pirhan O; Bayrak HI; Caglar IM; Karakaya O; Inci E
J Invasive Cardiol; 2013 Oct; 25(10):519-24. PubMed ID: 24088426
[TBL] [Abstract][Full Text] [Related]
11. Effect of percutaneous atrial septal defect and patent foramen ovale device closure on degree of aortic regurgitation.
Loar RW; Johnson JN; Cabalka AK; Cetta F; Hagler DJ; Eidem BW; Taggart NW
Catheter Cardiovasc Interv; 2013 Jun; 81(7):1234-7. PubMed ID: 23239614
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of randomized trials on percutaneous patent foramen ovale closure for prevention of migraine.
Elbadawi A; Barssoum K; Abuzaid AS; Rezq A; Biniwale N; Alotaki E; Mohamed AH; Vuyyala S; Ogunbayo GO; Saad M
Acta Cardiol; 2019 Apr; 74(2):124-129. PubMed ID: 29914296
[TBL] [Abstract][Full Text] [Related]
13. Comparison of residual shunt rates in five devices used to treat patent foramen ovale.
Matsumura K; Gevorgyan R; Mangels D; Masoomi R; Mojadidi MK; Tobis J
Catheter Cardiovasc Interv; 2014 Sep; 84(3):455-63. PubMed ID: 24550064
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous Closure of Patent Foramen Ovale in Patients With Migraine: The PREMIUM Trial.
Tobis JM; Charles A; Silberstein SD; Sorensen S; Maini B; Horwitz PA; Gurley JC
J Am Coll Cardiol; 2017 Dec; 70(22):2766-2774. PubMed ID: 29191325
[TBL] [Abstract][Full Text] [Related]
15. Association of interatrial shunts and migraine headaches: impact of transcatheter closure.
Azarbal B; Tobis J; Suh W; Chan V; Dao C; Gaster R
J Am Coll Cardiol; 2005 Feb; 45(4):489-92. PubMed ID: 15708691
[TBL] [Abstract][Full Text] [Related]
16. Transcatheter PFO closure with GORE(®) septal occluder: early and mid-term clinical results.
Butera G; Saracino A; Danna P; Sganzerla P; Chessa M; Carminati M
Catheter Cardiovasc Interv; 2013 Nov; 82(6):944-9. PubMed ID: 23897659
[TBL] [Abstract][Full Text] [Related]
17. Effect of Residual Interatrial Shunt on Migraine Burden After Transcatheter Closure of Patent Foramen Ovale.
Ben-Assa E; Rengifo-Moreno P; Al-Bawardy R; Kolte D; Cigarroa R; Cruz-Gonzalez I; Sakhuja R; Elmariah S; Pomerantsev E; Vaina LM; Ning M; Buonanno FS; Hung JW; Inglessis I; Palacios IF
JACC Cardiovasc Interv; 2020 Feb; 13(3):293-302. PubMed ID: 32029246
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous closure of patent foramen ovale for migraine headaches refractory to medical treatment.
Wahl A; Praz F; Findling O; Nedeltchev K; Schwerzmann M; Tai T; Windecker S; Mattle HP; Meier B
Catheter Cardiovasc Interv; 2009 Jul; 74(1):124-9. PubMed ID: 19180663
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous patent foramen ovale closure using Helex and Amplatzer devices without intraprocedural echocardiographic guidance.
Siddiqui IF; Michaels AD
J Interv Cardiol; 2011 Jun; 24(3):271-7. PubMed ID: 21114532
[TBL] [Abstract][Full Text] [Related]
20. Application of Transesophageal Echocardiography in Amplatzer Atrial Septal Defect Occluder for Percutaneous Closure of Large Patent Foramen Ovale.
Du Y; Xie H; Shao H; Cheng G; He L; Wang X; He X; Lan B; Zhang Y; Tian G
Cardiovasc Ther; 2022; 2022():3226080. PubMed ID: 35936794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]